Skip to main content
. 2017 Aug 25;17:592. doi: 10.1186/s12879-017-2693-1

Table 2.

Comparison of sensitivity, specificity, PPV, and NPV for individual parameters in 498 patients with aseptic loosening and prosthetic joint infection (18 early, 35 delayed and 77 late)

Diagnostic test AL PJI Specificity (%) Sensitivity (%) PPV (%) NPV (%) ROC área (95% CI) P-value*
TN/total TP/total (95% CI) (95% CI) (95% CI) (95% CI)
CRP (>1)
 All patients 310/367 90/128 84.5 (80.4–88.0) 70.3 (61.6–78.1) 61.2 (52.8–69.1) 89.1 (85.3–92.2) 0.774 (0.730–0.818) 0.124
 Early 10/13 13/16 76.9 (46.2–95.0) 81.3 (54.4–96.0) 81.3 (54.4–96.0) 76.9 (46.2–95.0) 0.791 (0.636–0.946)
 Delayed 20/23 29/35 87.0 (66.4–97.2) 82.9 (66.4–93.4) 90.6 (75.0–98.0) 76.9 (56.4–91.0) 0.849 (0.754–0.943)
 Late 280/331 48/77 84.6 (80.2–88.3) 62.3 (50.6–73.1) 48.5 (38.3–58.7) 90.6 (86.8–93.6) 0.735 (0.678–0.792)
Synovial fluid culture
 All patients 310/310 53/116 100 (98.8–100) 45.7 (36.4–55.2) 100 (93.3–100) 83.1 (78.9–86.8) 0.728 (0.683–0.774) 0.039
 Early 13/13 9/16 100 (75.3–100) 56.3 (29.9–80.2) 100 (66.4–100) 65.0 (40.8–84.6) 0.781 (0.656–0.906)
 Delayed 18/18 20/33 100 (81.5–100) 60.6 (42.1–77.1) 100 (83.2–100) 58.1 (39.1–75.5) 0.803 (0.718–0.888)
 Late 279/279 24/67 100 (98.7–100) 35.8 (24.5–48.5) 100 (85.8–100) 86.6 (82.4–90.2) 0.679 (0.621–0.736)
Peri-implant tissue culture
 All patients 367/368 81/130 99.7 (98.5–100) 62.3 (53.4–70.7) 98.8 (93.4–100) 88.2 (84.7–91.2) 0.810 (0.768–0.852) 0.033
 Early 13/13 15/18 100 (75.3–100) 83.3 (58.6–96.4) 100 (78.2–100) 81.3 (54.4–96.0) 0.917 (0.828–1.000)
 Delayed 24/24 23/35 100 (85.8–100) 65.7 (47.8–80.9) 100 (85.2–100) 66.7 (49.0–81.4) 0.829 (0.749–0.908)
 Late 330/331 43/77 99.7 (98.3–100) 55.8 (44.1–67.2) 97.7 (88.0–99.9) 90.7 (87.2–93.4) 0.778 (0.722–0.834)
Sonicate fluid culture
 All patients 366/368 110/130 99.5 (98.1–99.9) 84.6 (77.2–90.3) 98.2 (93.7–99.8) 94.8 (92.1–96.8) 0.920 (0.889–0.952) 0.402
 Early 13/13 15/18 100 (75.3–100) 83.3 (58.6–96.4) 100 (78.2–100) 81.3 (54.4–96.0) 0.917 (0.828–1.000)
 Delayed 23/24 33/35 95.8 (78.8–99.9) 94.3 (80.8–99.3) 97.1 (84.7–99.9) 92.0 (74.0–99.0) 0.951 (0.894–1.000)
 Late 330/331 62/77 99.7 (98.3–100) 80.5 (69.9–88.7) 98.4 (91.5–100) 95.7 (92.9–97.5) 0.901 (0.856–0.946)
Histology
 All patients 368/368 100/128 100 (99.0–100) 78.1 (70.0–84.9) 100 (96.4–100) 92.9 (89.9–95.3) 0.891 (0.855–0.927) 0.190
 Early 13/13 14/18 100 (75.0–100) 77.8 (52.4–93.6) 100 (76.8–100) 76.5 (50.1–93.2) 0.889 (0.790–0.987)
 Delayed 24/24 29/33 100 (85.8–100) 87.9 (71.8–96.6) 100 (88.1–100) 85.7 (67.3–95.9) 0.939 (0.883–0.996)
 Late 331/337 57/77 100 (98.9–100) 74.0 (62.8–83.4) 100 (93.7–100) 94.3 (91.3–96.4) 0.870 (0.821–0.919)

AL aseptic loosening, PJI prosthetic joint infection, TN true negative, TP true positive, CI confidence interval, PPV positive predictive value, NPV negative predictive value, CRP C-reactive protein

*Two sided P-value Test of equality of independent ROC areas in the three groups of patients with PJI: early, delayed and late